By modulating both the innate and adaptive arms of the immune system, Thymosin Alpha-1 has shown incredible promise in fields as diverse as infectious disease/infectious medicine, oncology, healthy aging, and functional medicine
Heres how it works: Impacting Growth Factors: BPC-157 activates the JAK2 signaling pathway and enhances growth hormone receptor activity, particularly in tendon cells
Instead of using the patients exhalation force, this device uses pressurized gas to emit the dose [6,9,10]
These findings have been corroborated by others, who have demonstrated elevated IFP in invasive ductal carcinomas relative to benign tumors or noninvasive carcinomas and a positive correlation between tumor size and IFP [12]
Patients can be counseled about potential risks and benefits and allowed to participate in informed decision-making